Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02195986Phase 3Completed
Phase 3, randomised, double-blind trial of estradiol topical in atrophic vaginitis (3 arms), sponsored by Mylan. Primary endpoint: Primary Endpoint (Vaginal Cytology + Vaginal pH) Equivalence and Comparison to Placebo at Day 8. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02195986.